Navigation Links
Inhibiting Blood to Save the Brain

A fibrous protein called fibrinogen, found in circulating blood and important in blood clotting, can promote multiple sclerosis (MS) when it //leaks from the blood into the brain, triggering inflammation that leads to MS-related nerve damage. Researchers at the University of California, San Diego (UCSD) School of Medicine have identified a fibrin-derived peptide that inhibits this specific inflammation process in mouse models of MS, reducing MS symptoms.

“Current strategies to develop therapies to fight MS primarily target T cells,” said Katerina Akassoglou, Ph.D., assistant professor in UCSD’s Department of Pharmacology, whose study was published in the March 19 issue of Journal of Experimental Medicine. “Blood proteins have been neglected as a therapeutic target, but this research shows that a blood clotting factor is an important player in MS.”

MS is an inflammatory disease that affects the central nervous system, causing symptoms such as loss of balance and muscle coordination, and changes in cognitive function. The disease is marked by loss of myelin, a material that coats nerve fibers. Past studies showed that the destruction of the myelin sheath is associated with the accumulation of fibrinogen deposits in the brain of human MS patients. In this study, Akassoglou and colleagues showed that fibrinogen is not merely associated with the damage in MS, but an active participant. Fibrinogen activates macrophage cells in the brain called microglia, causing inflammation which damages myelin.

The scientists sought to design a therapeutic strategy that would block the damaging effects of fibrinogen without affecting its beneficial blood coagulation. Studying a mouse model, the researchers identified a specific receptor called Mac-1 that is expressed by microglial cells and binds to fibrinogen. Mice expressing a mutant form of fibrinogen that failed to bind Mac-1 had fewer inflammatory lesions and less severe MS symptoms. Blocking th
'"/>




Page: 1 2

Related medicine news :

1. Sugars Could Contain Key Cancer Inhibiting Compounds
2. Recommendations for Treatment of Blood Pressue
3. Blood Cells Capable of Regenerating Liver
4. Blood clots likely in long travel
5. Hemochromatosis Patients Blood is Safe
6. Blood transfusions beneficial after heart attacks
7. Blood Pressure Drug may slow wasting in burn victims
8. Levels Of Blood Proteins May Help Heart Disease Care
9. Blood test may identify ovarian cancer
10. A Blood test for suicide risk?
11. Blood Pressure Drugs maintain muscle strength
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Inhibiting Blood Save the Brain

(Date:10/10/2008)...ng point for behavior change, DES MOINES, Iowa, O...,Americans (51 percent) believe there are good thi...r changes are needed, according to the 2008,EBRI H...oday by the,Employee Benefit Research Institute an...derwritten by the Principal Financial Group(R)., ...
(Date:10/10/2008)...dentialing Center (ANCC) has designated Geisinger ...s came via a conference call to hospital administr...and applause., GMC joins an elite group of only 1...n the United States that have achieved Magnet stat...s recognition., "Achieving Magnet designation is ...
(Date:10/10/2008)... blame , , FRIDAY, Oct. 10 (HealthDay Ne...ve diabetes, being depressed was associated with a..., Publishing in the October issue of the Journal...he University of Washington tracked 10,704 Medicar...d diabetes and were enrolled in a disease manageme...
(Date:10/10/2008)...llence in the implementation of electronic health ...agement Systems Society (HIMSS) announces the reci...onal, Ambulatory and Community Health Organization...L (PRWEB) October 10, 2008 -- Honoring excellence ... (EHRs), the Healthcare Information and Managemen...
Breaking Medicine News(10 mins):Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 2Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 3Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5
...e of the major cause of obesity- overeating, which...hat it could be addictive.// Researchers used an ...tomach to the brain to understand the exact road t...kes and the tough ride ahead for those in its grip...
...hers in the United States has discovered what may ...lon cancer.// The scientists from the University...h in mice by halting the activity of a single enzy.... Blocking this enzyme shuts down the toxic netwo...
...ges facing researchers today, and recent research ...ntain a growing epidemic.// The World Health Organ...ple in the world tackling overweight problems, of ...ientists have narrowed their sights on a new molec...
... won this year's Nobel Prize for Medicine in recog...ouble-stranded RNA, it was announced here Monday. ...RNA interference in awarding them the 10-million-k...e. The award winners have discovered "a fundament...
Other Medicine News:Health News:Brain behind the Brawn: Vital Molecule in the Brain Controls Appetite 2Health News:Two Americans Share 2006 Nobel Medicine Prize 2
(Date:10/10/2008)... SWARTZ CREEK, Mich., Oct. 10 /-...Teva Neuroscience has selected Diplomat,Specialty ...ate in a large,scale, national Therapy Optimizatio...l, of the two year TOP MS study, is to examine the...nt program on compliance, adherence and,patient ou...
(Date:10/9/2008)... North American Campaign to Spread Awareness ...ASHINGTON, Oct. 9 /PRNewswire-USNewswire/ -- 133 m...tal care due to causes such as natural,disaster, c... (SOS-USA) is,observing World Orphan Week by calli...To view the Multimedia News Release, go to:, htt...
(Date:10/9/2008)... STOCKHOLM, October 9 /PRNewswire-FirstCall/ ...fluential medical journal, the New England Journal...s from the company,s study,of the Diamyd(R) diabet...ww.newscom.com/cgi-bin/prnh/20080314/297194 ), T...ite,( http://www.nejm.org ) and will be in print o...
(Date:10/8/2008)... Review Zanolimumab Program to be Discontinued a...ces the Results of its Portfolio Review; Zanolimum...l Reduce the Number of ...irstCall/ -- Genmab A/S (OMX: GEN),announced today...ab,(HuMax-CD4(R)). In addition, as a result of a p...
Breaking Medicine Technology:Diplomat Specialty Pharmacy Tapped by Teva Neuroscience for Therapy Optimization Study for Multiple Sclerosis (TOP MS) 2Photos: SOS Children's Villages Observes World Orphan Week, October 5-11, 2008 2Diamyd(R) Study Published in Prestigious New England Journal of Medicine 2Diamyd(R) Study Published in Prestigious New England Journal of Medicine 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 4Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 2Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 3Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 4Scotlands economy challenged by population trends 7809 1Scotlands economy challenged by population trends 7809 2Economists 3A Reduce fish catch now for bigger net profits later 1492 1Economists 3A Reduce fish catch now for bigger net profits later 1492 2Economists 3A Reduce fish catch now for bigger net profits later 1492 3NutriSystem Advances Weight Loss Category 7804 1NutriSystem Advances Weight Loss Category 7804 2NutriSystem Advances Weight Loss Category 7804 3Mylan Receives 2426 2 Million From Exercise of Overallotment Option of Common Stock 7799 1Mylan Receives 2426 2 Million From Exercise of Overallotment Option of Common Stock 7799 2
...- Findings from an Otsuka Pharmaceutical Co, Ltd. ...ric Association Annual Meeting -, SAN DIEGO, May 2...lescents (13- 17 years old) with schizophrenia, th...s Squibb Company atypical,antipsychotic aripiprazo...o placebo on the primary efficacy endpoint, Positi...
... Schlieren (Zurich), Switzerland, May 24, 2007 - C...sults from a,placebo-controlled, double-blind comb...vaccine candidate for the treatment of,psoriasis a...y was,a first-time-in-man clinical trial and inclu...plaque psoriasis. In a first part,of the study, th...
Other Medicine Technology:Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 2Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 3Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 4Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 5Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 6Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 7Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 8Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 9Cytos Reports Results from Phase I/IIa Study with CYT007-TNFQb for,the Treatment of Psoriasis 2Cytos Reports Results from Phase I/IIa Study with CYT007-TNFQb for,the Treatment of Psoriasis 3Cytos Reports Results from Phase I/IIa Study with CYT007-TNFQb for,the Treatment of Psoriasis 4
Cold light source triple outlet.
Cold light source dual outlet.
Cold light source dual outlet.
The 4150S is a state of the art 150 Watt halogen light source with an integrated intensity control and a standard coupler to connect optical fiber light guides. This light source distinguishes itself
Medicine Products: